Ernexa Therapeutics, Inc. engages in the provision of cell engineering therapies. It is involved in the development of mRNA cell engineering technologies to repair cellular dysfunction and treat a range of therapeutic indications. The company was founded in 1984 and is headquartered in Cambridge, MA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
6
Frequently Asked Questions
What is Market Cap of Ernexa Therapeutics Inc.?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Ernexa Therapeutics Inc. market cap is $9.63M.
What is the 52-week high for Ernexa Therapeutics Inc.?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Ernexa Therapeutics Inc. 52 week high is $24.15 as of September 08, 2025.
What is the 52-week low for Ernexa Therapeutics Inc.?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Ernexa Therapeutics Inc. 52 week low is $1.21 as of September 08, 2025.
What is Ernexa Therapeutics Inc. stock price today?
Ernexa Therapeutics Inc. stock price today is $1.26.
What was Ernexa Therapeutics Inc. stock price yesterday?
Ernexa Therapeutics Inc. stock price yesterday was $1.22.
What is the PE ratio of Ernexa Therapeutics Inc.?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Ernexa Therapeutics Inc.’s P/E ratio is -0.02.
What is the Price-to-Book ratio of Ernexa Therapeutics Inc.?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Ernexa Therapeutics Inc. P/B ratio is 2.1137.
What is the 50-day moving average of Ernexa Therapeutics Inc.?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Ernexa Therapeutics Inc. 50-day moving average is $1.73.
How many employess does Ernexa Therapeutics Inc. has?
